Skip navigation
Speakers

Moving Beyond Theory — Strategic and Tactical Decisions for Long-Term Success

January 23-24, 2018
  • Alexandria, VA

Sheila Arquette, Executive Director
National Association of Specialty Pharmacy (NASP);
Strategic Pharmacy Projects Advisor, Independent Health

Molly Burich
Associate Director Public Policy
Boehringer Ingelheim

Ronald Dudek
Director, Adapter CAR Program Manager
Lentigen Technology, Inc.

Edric Engert
Managing Director
Abraxeolus Consulting

Thomas Felix, M.D.
Medical Director, R&D Policy, Intercontinental Region
Amgen

Joseph P. Fuhr Jr.
Lecturer, College of Population Health
Thomas Jefferson University

TJ Garrigan
Senior Director, Policy
Association for Accessible Medicines

John Greenaway
Principal
Trinity Partners LCC

Omar Hafez
Vice President, Multisource Products, Analytics
McKesson Specialty Health

Tom Keonig
Executive Director, Market Access, Biosimilars
Boehringer Ingelheim Pharmaceutical Inc.

Lawrence A. (Larry) La Motte
Vice President, Public Policy
Immune Deficiency Foundation and Representative
Patients for Biologics Safety and Access (PBSA)

Bruce Leicher
Senior Vice President and General Counsel
Momenta Pharmaceuticals, Inc.

Tiffany McCaslin
Senior Policy Analyst, Public Policy
National Business Group on Health

Lisa B. Pensabene
Partner
O'Melveny & Myers LLP

Pete Perron
Vice President and General Manager, GPO Services
McKesson Specialty Health

Nicholas Simmons-Stern
Senior Consultant
Trinity Partners, LLC

Eric R. Sjogren, MS, MBA, RPh
Director, Strategic Business Intelligence
Merck

James Van Lieshout
Pharmaceutical Industry Consultant
Self-Employed

Anna Rose Welch
Chief Editor, Biosimilar Development
Life Science Connect

Sheila Arquette, Executive Director
National Association of Specialty Pharmacy (NASP);
Strategic Pharmacy Projects Advisor, Independent Health

Molly Burich
Associate Director Public Policy
Boehringer Ingelheim

Ronald Dudek
Director, Adapter CAR Program Manager
Lentigen Technology, Inc.

Edric Engert
Managing Director
Abraxeolus Consulting

Thomas Felix, M.D.
Medical Director, R&D Policy, Intercontinental Region
Amgen

Joseph P. Fuhr Jr.
Lecturer, College of Population Health
Thomas Jefferson University

TJ Garrigan
Senior Director, Policy
Association for Accessible Medicines

John Greenaway
Principal
Trinity Partners LCC

Omar Hafez
Vice President, Multisource Products, Analytics
McKesson Specialty Health

Tom Keonig
Executive Director, Market Access, Biosimilars
Boehringer Ingelheim Pharmaceutical Inc.

Lawrence A. (Larry) La Motte
Vice President, Public Policy
Immune Deficiency Foundation and Representative
Patients for Biologics Safety and Access (PBSA)

Bruce Leicher
Senior Vice President and General Counsel
Momenta Pharmaceuticals, Inc.

Tiffany McCaslin
Senior Policy Analyst, Public Policy
National Business Group on Health

Lisa B. Pensabene
Partner
O'Melveny & Myers LLP

Pete Perron
Vice President and General Manager, GPO Services
McKesson Specialty Health

Nicholas Simmons-Stern
Senior Consultant
Trinity Partners, LLC

Eric R. Sjogren, MS, MBA, RPh
Director, Strategic Business Intelligence
Merck

James Van Lieshout
Pharmaceutical Industry Consultant
Self-Employed

Anna Rose Welch
Chief Editor, Biosimilar Development
Life Science Connect